Alternatives to Iktos

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Vivodyne is developing advanced AI models for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.

AI platform for accelerating novel peptide therapeutic discovery and development.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

AI platform accelerating the discovery of novel therapeutics.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.